1. Home
  2. WAFDP vs CGEN Comparison

WAFDP vs CGEN Comparison

Compare WAFDP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WaFd Inc. Depositary Shares

WAFDP

WaFd Inc. Depositary Shares

N/A

Current Price

$16.40

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.47

Market Cap

191.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFDP
CGEN
Founded
N/A
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
191.1M
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
WAFDP
CGEN
Price
$16.40
$2.47
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
11.8K
300.0K
Earning Date
N/A
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
5.20
N/A
EPS
2.45
N/A
Revenue
$29,650,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
$6.71
N/A
Revenue Growth
7.79
N/A
52 Week Low
$15.94
$1.30
52 Week High
$17.49
$3.24

Technical Indicators

Market Signals
Indicator
WAFDP
CGEN
Relative Strength Index (RSI) 42.45 46.09
Support Level $16.34 $2.23
Resistance Level $16.67 $2.54
Average True Range (ATR) 0.15 0.12
MACD -0.02 -0.03
Stochastic Oscillator 14.06 4.04

Price Performance

Historical Comparison
WAFDP
CGEN

About WAFDP WaFd Inc. Depositary Shares

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: